Cargando…

Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015

Shigellosis outbreaks caused by Shigella with decreased susceptibility to azithromycin (DSA-Shigella) among men who have sex with men (MSM) have been reported worldwide. We describe sexual health indicators and antimicrobial drug resistance for shigellosis cases in Minnesota, USA. We analyzed a samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Eikmeier, Dana, Talley, Pamela, Bowen, Anna, Leano, Fe, Dobbins, Ginette, Jawahir, Selina, Gross, Annastasia, Huspeni, Dawn, La Pointe, Allison, Meyer, Stephanie, Smith, Kirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101095/
https://www.ncbi.nlm.nih.gov/pubmed/32186495
http://dx.doi.org/10.3201/eid2604.191031
_version_ 1783511549153902592
author Eikmeier, Dana
Talley, Pamela
Bowen, Anna
Leano, Fe
Dobbins, Ginette
Jawahir, Selina
Gross, Annastasia
Huspeni, Dawn
La Pointe, Allison
Meyer, Stephanie
Smith, Kirk
author_facet Eikmeier, Dana
Talley, Pamela
Bowen, Anna
Leano, Fe
Dobbins, Ginette
Jawahir, Selina
Gross, Annastasia
Huspeni, Dawn
La Pointe, Allison
Meyer, Stephanie
Smith, Kirk
author_sort Eikmeier, Dana
collection PubMed
description Shigellosis outbreaks caused by Shigella with decreased susceptibility to azithromycin (DSA-Shigella) among men who have sex with men (MSM) have been reported worldwide. We describe sexual health indicators and antimicrobial drug resistance for shigellosis cases in Minnesota, USA. We analyzed a sample of isolates received during 2012–2015 and cross-referenced cases with the Minnesota Department of Health Sexually Transmitted Disease Database to ascertain patients’ HIV status and recent chlamydia, gonorrhea, and syphilis infections. Of 691 Shigella isolates, 46 (7%) were DSA-Shigella; 91% of DSA-Shigella patients were men, of whom 60% were living with HIV. Among men, those with DSA-Shigella infection had greater odds of living with HIV, identifying as MSM, or having a recent diagnosis of a sexually transmitted disease. DSA-Shigella was associated with MSM, HIV infection, and recent sexually transmitted disease. To decrease spread of DSA-Shigella, interventions targeted at communities at high risk are needed.
format Online
Article
Text
id pubmed-7101095
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-71010952020-04-03 Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 Eikmeier, Dana Talley, Pamela Bowen, Anna Leano, Fe Dobbins, Ginette Jawahir, Selina Gross, Annastasia Huspeni, Dawn La Pointe, Allison Meyer, Stephanie Smith, Kirk Emerg Infect Dis Synopsis Shigellosis outbreaks caused by Shigella with decreased susceptibility to azithromycin (DSA-Shigella) among men who have sex with men (MSM) have been reported worldwide. We describe sexual health indicators and antimicrobial drug resistance for shigellosis cases in Minnesota, USA. We analyzed a sample of isolates received during 2012–2015 and cross-referenced cases with the Minnesota Department of Health Sexually Transmitted Disease Database to ascertain patients’ HIV status and recent chlamydia, gonorrhea, and syphilis infections. Of 691 Shigella isolates, 46 (7%) were DSA-Shigella; 91% of DSA-Shigella patients were men, of whom 60% were living with HIV. Among men, those with DSA-Shigella infection had greater odds of living with HIV, identifying as MSM, or having a recent diagnosis of a sexually transmitted disease. DSA-Shigella was associated with MSM, HIV infection, and recent sexually transmitted disease. To decrease spread of DSA-Shigella, interventions targeted at communities at high risk are needed. Centers for Disease Control and Prevention 2020-04 /pmc/articles/PMC7101095/ /pubmed/32186495 http://dx.doi.org/10.3201/eid2604.191031 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Eikmeier, Dana
Talley, Pamela
Bowen, Anna
Leano, Fe
Dobbins, Ginette
Jawahir, Selina
Gross, Annastasia
Huspeni, Dawn
La Pointe, Allison
Meyer, Stephanie
Smith, Kirk
Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015
title Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015
title_full Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015
title_fullStr Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015
title_full_unstemmed Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015
title_short Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015
title_sort decreased susceptibility to azithromycin in clinical shigella isolates associated with hiv and sexually transmitted bacterial diseases, minnesota, usa, 2012–2015
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101095/
https://www.ncbi.nlm.nih.gov/pubmed/32186495
http://dx.doi.org/10.3201/eid2604.191031
work_keys_str_mv AT eikmeierdana decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT talleypamela decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT bowenanna decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT leanofe decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT dobbinsginette decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT jawahirselina decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT grossannastasia decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT huspenidawn decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT lapointeallison decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT meyerstephanie decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015
AT smithkirk decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015